These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18195060)

  • 1. Selection for high-level telithromycin resistance in Staphylococcus aureus yields mutants resulting from an rplB-to-rplV gene conversion-like event.
    Gentry DR; Holmes DJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1156-8. PubMed ID: 18195060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to telithromycin is conferred by msr(A), msrC and msr(D) in Staphylococcus aureus.
    Reynolds ED; Cove JH
    J Antimicrob Chemother; 2005 Dec; 56(6):1179-80. PubMed ID: 16223938
    [No Abstract]   [Full Text] [Related]  

  • 3. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22.
    Berisio R; Corti N; Pfister P; Yonath A; Böttger EC
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3816-23. PubMed ID: 16923950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.
    Davis KA; Crawford SA; Fiebelkorn KR; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3059-61. PubMed ID: 15980400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae.
    Hisanaga T; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Sep; 56(3):447-50. PubMed ID: 16006449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations at the Ribosomal S10 Gene in Clinical Strains of Staphylococcus aureus with Reduced Susceptibility to Tigecycline.
    Argudín MA; Roisin S; Dodémont M; Nonhoff C; Deplano A; Denis O
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
    Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
    Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status.
    Schmitz FJ; Petridou J; Milatovic D; Verhoef J; Fluit AC; Schwarz S
    J Antimicrob Chemother; 2002 Mar; 49(3):580-2. PubMed ID: 11864966
    [No Abstract]   [Full Text] [Related]  

  • 10. High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
    Wolter N; Smith AM; Low DE; Klugman KP
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1092-5. PubMed ID: 17210764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of L4 ribosomal protein conferring unusual macrolide resistance in two independent clinical isolates of Staphylococcus aureus.
    Prunier AL; Trong HN; Tande D; Segond C; Leclercq R
    Microb Drug Resist; 2005; 11(1):18-20. PubMed ID: 15770089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of Staphylococcus aureus to new macrolide antibiotics].
    Sacha P; Wieczorek P; Jakoniuk P
    Przegl Lek; 2008; 65(5):225-8. PubMed ID: 18853646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
    Gentry DR; Rittenhouse SF; McCloskey L; Holmes DJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2048-52. PubMed ID: 17404009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.
    Kosowska-Shick K; Clark C; Credito K; McGhee P; Dewasse B; Bogdanovich T; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Feb; 50(2):765-9. PubMed ID: 16436741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics of telithromycin and clarithromycin with Streptococcus pneumoniae and Staphylococcus aureus in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations.
    Alferova IV; Vostrov SN; Portnoy YA; Lubenko IY; Zinner SH; Firsov AA
    Int J Antimicrob Agents; 2005 Sep; 26(3):197-204. PubMed ID: 16122914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
    Schmitz FJ; Petridou J; Astfalk N; Köhrer K; Scheuring S; Schwarz S
    Microb Drug Resist; 2002; 8(3):171-7. PubMed ID: 12363005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ClpP-independent function of ClpX interferes with telithromycin resistance conferred by Msr(A) in Staphylococcus aureus.
    Vimberg V; Lenart J; Janata J; Balikova Novotna G
    Antimicrob Agents Chemother; 2015; 59(6):3611-4. PubMed ID: 25801573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.